Emergent BioSolutions, Inc. (EBS)
8.635
-0.02
(-0.29%)
USD |
NYSE |
Apr 16, 16:00
8.79
+0.16
(+1.80%)
After-Hours: 17:04
Emergent BioSolutions Research and Development Expense (Annual) : 53.80M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Eli Lilly & Co. | 13.34B |
| Penumbra, Inc. | 69.43M |
| Disc Medicine, Inc. | 170.36M |
| MetaVia, Inc. | 6.802M |